Thomas Hope, MD

Title(s)Professor, Radiology
SchoolSchool of Medicine
Address185 Berry Street Bldg B, #395
San Francisco CA 94158
Phone415-221-4810 ext. 22648
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Society of Nuclear Medicine and Molecular Imaging2020Hal O’Brien Rising Star Award Winner
    North American Neuroendocrine Tumor Society2018Theragnostics Investigator Award
    Prostate Cancer Foundation2017Young Investigator Award
    Society of Nuclear Medicine and Molecular Imaging2016Marc Tetalman Award
    Society of Nuclear Medicine and Molecular Imaging2016Henkin Fellowship
    Society of Abdominal Radiology2014Wylie J. Dodds Research Award
    University of California, San Francisco 2012Alexander Margulis Society Outstanding Research Award
    Radiological Society of North America2012Roentgen Resident/Fellow Research Award
    Radiological Society of North America2010Presidents Circle Research Resident Grant
    ISMRM2007W.S. Moore Award Nominee
    Radiological Society of North America2006Trainee Research Prize

    Collapse Overview 
    Collapse Overview
    Thomas Hope, MD, is the Vice Chair of Clinical Operations and Strategy in the Department of Radiology. He also serves as the Director of Molecular Therapy. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center and as chair of the Cancer Center’s Molecular Imaging & Radionuclide Therapy Site Committee. In 2007, he received his medical degree from Stanford University School of Medicine and he completed a one-year internship at Kaiser Permanente, San Francisco. From 2008-2012, Dr. Hope completed a residency in Diagnostic Radiology at the University of California, San Francisco, followed by a clinical fellowship in Body MRI and Nuclear Medicine from Stanford Medical Center in 2013.

    Dr. Hope’s main research focus is on novel imaging agents and therapies, particularly in prostate cancer and neuroendocrine tumors. He lead the development of Ga-68 PSMA-11, which subsequently led to the approval of this drug by the FDA. He has combined his interest in MR imaging with PET in the simultaneous modality PET/MRI, helping lead the development of the clinical PET/MRI program. Additionally he leads the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors and PSMA Radioligand Therapy at UCSF.

    An international leader in PET/MR research and the translation of new molecular imaging agents, Dr. Hope launched the highly successful PSMA prostate program at UCSF and championed the use of multiple new targeted therapies to treat patients with neuroendocrine and other tumors. He current serves as principal investigator on grants from the NIH, the Prostate Cancer Foundation. He is the recipient of numerous accolades in molecular imaging, including the Henkin Fellow and Marc Tetalman Memorial Award from the Society of Nuclear Medicine and Molecular Imaging, the Young Investigator Award from the Prostate Cancer Foundation and the Wylie J. Dodds Research Award from the Society of Abdominal Radiology.

    Expertise:
    Abdominal Imaging and Nuclear Medicine, and Molecular Imaging and Therapeutics

    Professional Interests:
    Novel imaging agents, PET/MR, prostate cancer, neuroendocrine tumor, radioligand therapy

    Education and Training:
    • Medical School: Stanford University School of Medicine, California
    • Internship: Kaiser Permanente, San Francisco, California
    • Residency: University of California, San Francisco - Diagnostic Radiology
    • Fellowship: Stanford Medical Center, California - Body MRI and Nuclear Medicine
    • California Medical License
    • American Board of Radiology, Certificate in Diagnostic Radiology
    • American Board of Nuclear Medicine, Certificate in Nuclear Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    MELT: Modulation of PSMA Expression for Lutetium Therapy
    NIH R01CA235741Jul 1, 2019 - Jun 30, 2025
    Role: Principal Investigator
    Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer
    NIH R01CA229354Jun 1, 2019 - Apr 30, 2021
    Role: Co-Principal Investigator
    Qualification and Harmonization of PET/MRI for Cancer Clinical Trials
    NIH R01CA212148Mar 6, 2017 - Feb 28, 2023
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mixed Supervision of Histopathology Improves Prostate Cancer Classification from MRI. IEEE Trans Med Imaging. 2024 Mar 28; PP. Rajagopal A, Westphalen AC, Velarde N, Simko JP, Nguyen H, Hope TA, Larson PEZ, Magudia K. PMID: 38547000.
      View in: PubMed   Mentions:    Fields:    
    2. Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study. Eur Urol. 2024 Mar 14. Weber M, Fendler WP, Ravi Kumar AS, Calais J, Czernin J, Ilhan H, Saad F, Kretschmer A, Hekimsoy T, Brookman-May SD, Mundle SD, Small EJ, Smith MR, Perez PM, Hope TA, Herrmann K, Hofman MS, Eiber M, Hadaschik BA. PMID: 38490855.
      View in: PubMed   Mentions:    Fields:    
    3. Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval. J Nucl Med. 2024 Mar 14. Tuchayi AM, Yadav S, Jiang F, Kim ST, Saelee RK, Morley A, Juarez R, Lawhn-Heath C, Wang Y, de Kouchkovsky I, Hope TA. PMID: 38485274.
      View in: PubMed   Mentions:    Fields:    
    4. Rethinking Dosimetry: The Perils of Extrapolated External-Beam Radiotherapy Constraints to Radionuclide Therapy. J Nucl Med. 2024 Mar 01; 65(3):362-364. Strosberg J, Hofman MS, Al-Toubah T, Hope TA. PMID: 38212065.
      View in: PubMed   Mentions: 1     Fields:    
    5. The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy. J Nucl Med. 2024 Mar 01; 65(3):409-415. Yadav S, Lawhn-Heath C, Paciorek A, Lindsay S, Mirro R, Bergsland EK, Hope TA. PMID: 38428966.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Technical note: Errors introduced when using Dose Voxel Kernels for estimating absorbed dose from radiopharmaceutical therapies involving alpha emitters. Med Phys. 2024 Feb 05. Tranel J, Palm S, Feng FY, St James S, Hope TA. PMID: 38314904.
      View in: PubMed   Mentions:    Fields:    
    7. Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer. J Nucl Med. 2024 Feb 01; 65(2):199-205. Koshkin VS, Kumar V, Kline B, Escobar D, Aslam M, Cooperberg MR, Aggarwal RR, de Kouchkovsky I, Chou J, Meng MV, Friedlander T, Porten S, Hope TA. PMID: 38212070.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774). Eur Urol. 2024 Jan 29. Armstrong WR, Kishan AU, Booker KM, Grogan TR, Elashoff D, Lam EC, Clark KJ, Steinberg ML, Fendler WP, Hope TA, Nickols NG, Czernin J, Calais J. PMID: 38290964.
      View in: PubMed   Mentions:    Fields:    
    9. PSMA PET AUC Updates: Inclusion of rh-PSMA-7.3. J Nucl Med. 2024 Jan 04. Hope TA, Jadvar H. PMID: 38176725.
      View in: PubMed   Mentions:    Fields:    
    10. Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database. J Nucl Med. 2024 Jan 02; 65(1):94-99. Emmett L, Papa N, Counter W, Calais J, Barbato F, Burger I, Eiber M, Roberts MJ, Agrawal S, Franklin A, Xue A, Rasiah K, John N, Moon D, Frydenberg M, Yaxley J, Stricker P, Wong K, Coughlin G, Gianduzzo T, Kua B, Ho B, Nguyen A, Liu V, Lee J, Hsiao E, Sutherland T, Perry E, Fendler WP, Hope TA. PMID: 38050155.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Correction to: PET/MRI in colorectal and anal cancers: an update. Abdom Radiol (NY). 2023 Dec; 48(12):3584. Jayaprakasam VS, Ince S, Suman G, Nepal P, Hope TA, Paspulati RM, Fraum TJ. PMID: 37994921.
      View in: PubMed   Mentions:    Fields:    
    12. Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial. Lancet Oncol. 2023 Nov; 24(11):1266-1276. Aggarwal R, Starzinski S, de Kouchkovsky I, Koshkin V, Bose R, Chou J, Desai A, Kwon D, Kaushal S, Trihy L, Rastogi M, Ippisch R, Aslam M, Friedlander T, Feng F, Oh D, Cheung A, Small E, Evans M, Fong L, Hope TA. PMID: 37922930; PMCID: PMC10667020.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    13. Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting. J Natl Cancer Inst. 2023 09 07; 115(9):1001-1010. Singh S, Hope TA, Bergsland EB, Bodei L, Bushnell DL, Chan JA, Chasen BR, Chauhan A, Das S, Dasari A, Del Rivero J, El-Haddad G, Goodman KA, Halperin DM, Lewis MA, Lindwasser OW, Myrehaug S, Raj NP, Reidy-Lagunes DL, Soares HP, Strosberg JR, Kohn EC, Kunz PL, NET CTPM participants . PMID: 37255328; PMCID: PMC10483264.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology. Eur J Nucl Med Mol Imaging. 2023 Oct; 50(12):3513-3537. Veit-Haibach P, Ahlström H, Boellaard R, Delgado Bolton RC, Hesse S, Hope T, Huellner MW, Iagaru A, Johnson GB, Kjaer A, Law I, Metser U, Quick HH, Sattler B, Umutlu L, Zaharchuk G, Herrmann K. PMID: 37624384; PMCID: PMC10547645.
      View in: PubMed   Mentions: 5     Fields:    
    15. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers. J Nucl Med. 2023 11; 64(11):1744-1747. Hope TA, Benz M, Jiang F, Thompson D, Barbato F, Juarez R, Hernandez Pampaloni M, Allen-Auerbach M, Gupta P, Fendler WP, Calais J. PMID: 37591547.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial. Eur Urol. 2023 12; 84(6):588-596. Djaïleb L, Armstrong WR, Thompson D, Gafita A, Farolfi A, Rajagopal A, Grogan TR, Nguyen K, Benz MR, Hotta M, Barbato F, Ceci F, Schwarzenböck SM, Unterrainer M, Zacho HD, Juarez R, Cooperberg M, Carroll P, Washington S, Reiter RE, Eiber M, Herrmann K, Fendler WP, Czernin J, Hope TA, Calais J. PMID: 37482512.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    17. Prostate-specific Membrane Antigen Reporting and Data System Version 2.0. Eur Urol. 2023 Nov; 84(5):491-502. Werner RA, Hartrampf PE, Fendler WP, Serfling SE, Derlin T, Higuchi T, Pienta KJ, Gafita A, Hope TA, Pomper MG, Eiber M, Gorin MA, Rowe SP. PMID: 37414701.
      View in: PubMed   Mentions:    Fields:    
    18. SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy. J Nucl Med. 2023 09; 64(9):1417-1423. Hope TA, Antonarakis ES, Bodei L, Calais J, Iravani A, Jacene H, Koo PJ, Morgans AK, Osborne JR, Tagawa ST, Taplin ME, Sartor O, Morris MJ. PMID: 37290800.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2023 07; 50(9):2830-2845. Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. PMID: 37246997; PMCID: PMC10317889.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    20. 68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study. J Nucl Med. 2023 07; 64(7):1043-1048. Mei R, Kessler L, Pabst KM, Weber M, Schmidkonz C, Rischpler C, Zacho HD, Hope T, Schwarzenböck SM, Allen-Auerbach M, Emmett L, Ferdinandus J, Unterrainer M, Schaarschmidt BM, Umutlu L, Farolfi A, Castellucci P, Nanni C, Telo S, Fanti S, Herrmann K, Fendler WP. PMID: 37230530.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas. Br J Cancer. 2023 08; 129(2):291-300. Raj N, Chan JA, Wang SJ, Aggarwal RR, Calabrese S, DeMore A, Fong L, Grabowsky J, Hope TA, Kolli KP, Mulvey CK, Munster PN, Perez K, Punn S, Reidy-Lagunes D, Von Fedak S, Zhang L, Bergsland EK. PMID: 37208512; PMCID: PMC10338510.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    22. Editorial Comment. J Urol. 2023 Aug; 210(2):299-311. Eifer M, Hope TA, Calais J, Hofman MS. PMID: 37203346.
      View in: PubMed   Mentions:    Fields:    
    23. Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel. Abdom Radiol (NY). 2023 09; 48(9):2792-2806. Lee S, Kassam Z, Baheti AD, Hope TA, Chang KJ, Korngold EK, Taggart MW, Horvat N. PMID: 37145311; PMCID: PMC10444656.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. PET/MRI in colorectal and anal cancers: an update. Abdom Radiol (NY). 2023 12; 48(12):3558-3583. Jayaprakasam VS, Ince S, Suman G, Nepal P, Hope TA, Paspulati RM, Fraum TJ. PMID: 37062021.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time. J Neuroendocrinol. 2023 04; 35(4):e13260. Wang SJ, Whitman J, Paciorek A, Le BK, Nakakura EK, Behr SC, Joseph N, Zhang L, Hope TA, Bergsland EK. PMID: 37002881.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study. J Nucl Med. 2023 07; 64(7):1024-1029. Hotta M, Gafita A, Murthy V, Benz MR, Sonni I, Burger IA, Eiber M, Emmett L, Farolfi A, Fendler WP, Weber MM, Hofman MS, Hope TA, Kratochwil C, Czernin J, Calais J. PMID: 36997329.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology. Abdom Radiol (NY). 2023 09; 48(9):3022-3032. Golia Pernicka JS, Rauch GM, Gangai N, Bates DDB, Ernst R, Hope TA, Horvat N, Sheedy SP, Gollub MJ. PMID: 36932225; PMCID: PMC10929685.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2). Eur Urol. 2023 05; 83(5):405-412. Seifert R, Emmett L, Rowe SP, Herrmann K, Hadaschik B, Calais J, Giesel FL, Reiter R, Maurer T, Heck M, Gafita A, Morris MJ, Fanti S, Weber WA, Hope TA, Hofman MS, Fendler WP, Eiber M. PMID: 36935345.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    29. Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios. Abdom Radiol (NY). 2023 05; 48(5):1843-1853. Konstantinoff KS, Morani AC, Hope TA, Bhosale PR, Francis IR, Yano M, Iravani A, Trikalinos NA, Itani M. PMID: 36737523.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors. J Nucl Med. 2023 02; 64(2):204-210. Hope TA, Allen-Auerbach M, Bodei L, Calais J, Dahlbom M, Dunnwald LK, Graham MM, Jacene HA, Heath CL, Mittra ES, Wright CL, Fendler WP, Herrmann K, Taïeb D, Kjaer A. PMID: 36725249.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    31. Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A. JCO Oncol Pract. 2023 03; 19(3):132-135. Garje R, Hope TA, Rumble RB, Parikh RA, Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer . PMID: 36693228.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023 04; 50(5):1466-1486. Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K, Haberkorn U, Jacene H, Koo PJ, Kopka K, Krause BJ, Lindenberg L, Marcus C, Mottaghy FM, Oprea-Lager DE, Osborne JR, Piert M, Rowe SP, Schöder H, Wan S, Wester HJ, Hope TA, Herrmann K. PMID: 36604326; PMCID: PMC10027805.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    33. Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET. Cancers (Basel). 2022 Dec 15; 14(24). Sabbagh A, Mohamad O, Lichter KE, Hope TA. PMID: 36551678.
      View in: PubMed   Mentions: 5  
    34. Using PSMA imaging for prognostication in localized and advanced prostate cancer. Nat Rev Urol. 2023 01; 20(1):23-47. Roberts MJ, Maurer T, Perera M, Eiber M, Hope TA, Ost P, Siva S, Hofman MS, Murphy DG, Emmett L, Fendler WP. PMID: 36473945.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    35. Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Urol Oncol. 2023 03; 41(3):145.e7-145.e15. Kwon DH, Shakhnazaryan N, Shui D, Hong JC, Mohamad O, de Kouchkovsky I, Borno HT, Bose R, Chou J, Desai A, Fong L, Friedlander TW, Koshkin VS, Aggarwal RR, Feng FY, Hope TA, Small EJ. PMID: 36435709.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Synthetic PET via Domain Translation of 3-D MRI. IEEE Trans Radiat Plasma Med Sci. 2023 Apr; 7(4):333-343. Rajagopal A, Natsuaki Y, Wangerin K, Hamdi M, An H, Sunderland JJ, Laforest R, Kinahan PE, Larson PEZ, Hope TA. PMID: 37396797; PMCID: PMC10311993.
      View in: PubMed   Mentions: 2  
    37. Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model. EJNMMI Phys. 2022 Sep 30; 9(1):67. Tranel J, Palm S, Graves SA, Feng FY, Hope TA. PMID: 36178531; PMCID: PMC9525486.
      View in: PubMed   Mentions: 1  
    38. Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans. Eur J Nucl Med Mol Imaging. 2022 09; 49(11):3761-3771. Polvoy I, Seo Y, Parker M, Stewart M, Siddiqua K, Manacsa HS, Ravanfar V, Blecha J, Hope TA, Vanbrocklin H, Flavell RR, Barry J, Hansen E, Villanueva-Meyer JE, Engel J, Rosenberg OS, Wilson DM, Ohliger MA. PMID: 35732972; PMCID: PMC9399217.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    39. ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy. Clin Nucl Med. 2022 Jun 01; 47(6):503-511. Love C, Desai NB, Abraham T, Banks KP, Bodei L, Boike T, Brown RKJ, Bushnell DL, DeBlanche LE, Dominello MM, Francis T, Grady EC, Hobbs RF, Hope TA, Kempf JS, Pryma DA, Rule W, Savir-Baruch B, Sethi I, Subramaniam RM, Xiao Y, Schechter NR. PMID: 35507433.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time? J Clin Oncol. 2022 08 20; 40(24):2818-2829. Hope TA, Pavel M, Bergsland EK. PMID: 35649195; PMCID: PMC9390818.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. Choice Is Good at Times: The Emergence of [64Cu]Cu-DOTATATE-Based Somatostatin Receptor Imaging in the Era of [68Ga]Ga-DOTATATE. J Nucl Med. 2022 09; 63(9):1300-1301. Jha A, Patel M, Carrasquillo JA, Chen CC, Millo C, Maass-Moreno R, Ling A, Lin FI, Lechan RM, Hope TA, Taïeb D, Civelek AC, Pacak K. PMID: 35618479; PMCID: PMC9454463.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy. Am J Clin Oncol. 2022 06 01; 45(6):233-242. Love C, Desai NB, Abraham T, Banks KP, Bodei L, Boike T, Brown RKJ, Bushnell DL, DeBlanche LE, Dominello MM, Francis T, Grady EC, Hobbs RF, Hope TA, Kempf JS, Pryma DA, Rule W, Savir-Baruch B, Sethi I, Subramaniam RM, Xiao Y, Schechter NR. PMID: 35507413.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Updates to Appropriate Use Criteria for PSMA PET. J Nucl Med. 2022 05; 63(5):14N. Hope TA, Jadvar H. PMID: 35487567.
      View in: PubMed   Mentions: 2     Fields:    
    44. Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope. J Nucl Med. 2022 04; 63(4):497-499. Mailman J, Hope TA. PMID: 35361712.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Best Approaches and Updates for Prostate Cancer Biochemical Recurrence. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-8. Simon NI, Parker C, Hope TA, Paller CJ. PMID: 35503984.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    46. PSMA PET in Prostate Cancer-A Biomarker or a Surrogate End Point?-Reply. JAMA Oncol. 2022 04 01; 8(4):1. Hope TA, Calais J. PMID: 35175289.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Impact of Implicit Abdominal Aortic Aneurysm Screening in the Veterans Affairs Health Care System Over 10 Years. J Am Heart Assoc. 2022 04 05; 11(7):e024571. Leach JR, Shen H, Huo E, Hope TA, Mitsouras D, Whooley MA, Hope MD. PMID: 35348001; PMCID: PMC9075479.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    48. The PRIMARY Score: Using Intraprostatic 68Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis. J Nucl Med. 2022 11; 63(11):1644-1650. Emmett L, Papa N, Buteau J, Ho B, Liu V, Roberts M, Thompson J, Moon D, Sheehan-Dare G, Alghazo O, Agrawal S, Murphy D, Stricker P, Hope TA, Hofman MS. PMID: 35301240; PMCID: PMC9635676.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    49. Reply: Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics. J Nucl Med. 2022 05; 63(5):804. Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. PMID: 35273095.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    50. Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose. Lancet Oncol. 2022 02; 23(2):e75-e87. Lawhn-Heath C, Hope TA, Martinez J, Fung EK, Shin J, Seo Y, Flavell RR. PMID: 35114134.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    51. Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups. J Clin Oncol. 2022 05 01; 40(13):1500-1505. Schöder H, Hope TA, Knopp M, Kelly WK, Michalski JM, Lerner SP, Tawab-Amiri A, Mann BS, Lin DW, Yu EY, Chen RC, Beach GC, Reeves SA, Members of the Working Group, Shankar LK. PMID: 35015566; PMCID: PMC9851697.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    52. Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips. Biosens Bioelectron. 2022 Mar 01; 199:113854. Sun N, Yang Y, Miao H, Redublo P, Liu H, Liu W, Huang YW, Teng PC, Zhang C, Zhang RY, Smalley M, Yang P, Chou SJ, Huai K, Zhang Z, Lee YT, Wang JJ, Wang J, Liang IY, Zhang TX, Zhang D, Liang L, Weiss PS, Posadas EM, Donahue T, Hecht JR, Allen-Auerbach MS, Bergsland EK, Hope TA, Pei R, Zhu Y, Tseng HR, Heaney AP. PMID: 34896918; PMCID: PMC8900541.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    53. Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice. J Nucl Med. 2021 Dec; 62(Suppl 3):60S-72S. Pandit-Taskar N, Iravani A, Lee D, Jacene H, Pryma D, Hope T, Saboury B, Capala J, Wahl RL. PMID: 34857623.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    54. Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns. J Nucl Med. 2021 12; 62(Suppl 3):12S-22S. Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. PMID: 34857617.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    55. Response to "Preoperative localization in primary hyperparathyroidism: Views from the developing world". Surgery. 2022 02; 171(2):564. Graves CE, Hope TA, Suh I. PMID: 34815096.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Harmonization of PET image reconstruction parameters in simultaneous PET/MRI. EJNMMI Phys. 2021 Nov 05; 8(1):75. Laforest R, Khalighi M, Natsuaki Y, Rajagopal A, Chandramohan D, Byrd D, An H, Larson P, James SS, Sunderland JJ, Kinahan PE, Hope TA. PMID: 34739621; PMCID: PMC8571452.
      View in: PubMed   Mentions: 1  
    57. Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial. JAMA Oncol. 2021 Nov 01; 7(11):1635-1642. Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, Reiter RE, Holden S, Herrmann K, Zhu S, Fendler WP, Czernin J, Calais J. PMID: 34529005; PMCID: PMC8446902.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    58. Preoperative risk stratification of lymph node metastasis for non-functional pancreatic neuroendocrine neoplasm: An international dual-institutional study. Pancreatology. 2022 Jan; 22(1):123-129. Kasai Y, Masui T, Nakakura EK, Nakano K, Sato A, Uchida Y, Yogo A, Nagai K, Anazawa T, Hope TA, Kim GE, Whitman J, Le BK, Takaori K, Bergsland EK, Hatano E, Uemoto S. PMID: 34736838.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study. J Nucl Med. 2022 01; 63(1):76-80. Ferdinandus J, Fendler WP, Farolfi A, Washington S, Mohamad O, Pampaloni MH, Scott PJH, Rodnick M, Viglianti BL, Eiber M, Herrmann K, Czernin J, Armstrong WR, Calais J, Hope TA, Piert M. PMID: 34620731; PMCID: PMC8717195.
      View in: PubMed   Mentions: 12     Fields:    
    60. Attenuation Coefficient Estimation for PET/MRI With Bayesian Deep Learning Pseudo-CT and Maximum-Likelihood Estimation of Activity and Attenuation. IEEE Trans Radiat Plasma Med Sci. 2022 Jul; 6(6):678-689. Leynes AP, Ahn S, Wangerin KA, Kaushik SS, Wiesinger F, Hope TA, Larson PEZ. PMID: 38223528; PMCID: PMC10785227.
      View in: PubMed   Mentions:
    61. Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging. J Nucl Med. 2022 01; 63(1):59-68. Jadvar H, Calais J, Fanti S, Feng F, Greene KL, Gulley JL, Hofman M, Koontz BF, Lin DW, Morris MJ, Rowe SP, Royce TJ, Salami S, Savir-Baruch B, Srinivas S, Hope TA. PMID: 34593595; PMCID: PMC8717184.
      View in: PubMed   Mentions: 20     Fields:    
    62. Evaluation of attenuation correction in PET/MRI with synthetic lesion insertion. J Med Imaging (Bellingham). 2021 Sep; 8(5):056001. Hamdi M, Natsuaki Y, Wangerin KA, An H, St James S, Kinahan PE, Sunderland JJ, Larson PEZ, Hope TA, Laforest R. PMID: 34568511; PMCID: PMC8451234.
      View in: PubMed   Mentions: 4  
    63. RESIST-PC: U.S. Academic Foray into PSMA Theranostic Trials. J Nucl Med. 2021 10; 62(10):1438-1439. Iravani A, Hope TA. PMID: 34353872.
      View in: PubMed   Mentions:    Fields:    
    64. A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States. Surgery. 2022 01; 171(1):55-62. Yap A, Hope TA, Graves CE, Kluijfhout W, Shen WT, Gosnell JE, Sosa JA, Roman SA, Duh QY, Suh I. PMID: 34340823.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    65. A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients. J Nucl Med. 2022 04; 63(4):567-572. Abghari-Gerst M, Armstrong WR, Nguyen K, Calais J, Czernin J, Lin D, Jariwala N, Rodnick M, Hope TA, Hearn J, Montgomery JS, Alva A, Reichert ZR, Spratt DE, Johnson TD, Scott PJH, Piert M. PMID: 34326126; PMCID: PMC8973291.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    66. Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects. J Nucl Med. 2021 10; 62(10):1323-1329. Park S, Parihar AS, Bodei L, Hope TA, Mallak N, Millo C, Prasad K, Wilson D, Zukotynski K, Mittra E. PMID: 34301785; PMCID: PMC9364764.
      View in: PubMed   Mentions: 16     Fields:    
    67. A Path to Qualification of PET/MRI Scanners for Multicenter Brain Imaging Studies: Evaluation of MRI-Based Attenuation Correction Methods Using a Patient Phantom. J Nucl Med. 2022 04; 63(4):615-621. Catana C, Laforest R, An H, Boada F, Cao T, Faul D, Jakoby B, Jansen FP, Kemp BJ, Kinahan PE, Larson P, Levine MA, Maniawski P, Mawlawi O, McConathy JE, McMillan AB, Price JC, Rajagopal A, Sunderland J, Veit-Haibach P, Wangerin KA, Ying C, Hope TA. PMID: 34301784; PMCID: PMC8973286.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    68. Superior sensitivity of 18F-fluorocholine: PET localization in primary hyperparathyroidism. Surgery. 2022 01; 171(1):47-54. Graves CE, Hope TA, Kim J, Pampaloni MH, Kluijfhout W, Seib CD, Gosnell JE, Shen WT, Roman SA, Sosa JA, Duh QY, Suh I. PMID: 34301418.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    69. Perspectives on Radiopharmaceutical Agents from the FDA: A Conversation between Lou Marzella, Johannes Czernin, and Thomas Hope. J Nucl Med. 2021 07 01; 62(7):881-883. Marzella L, Czernin J, Hope T. PMID: 34244366.
      View in: PubMed   Mentions:    Fields:    
    70. Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: a narrative review. Transl Androl Urol. 2021 Jul; 10(7):3130-3143. de Kouchkovsky I, Aggarwal R, Hope TA. PMID: 34430416; PMCID: PMC8350242.
      View in: PubMed   Mentions: 3  
    71. A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria? Eur J Nucl Med Mol Imaging. 2021 12; 48(13):4463-4471. Salavati A, Gencturk M, Koksel Y, Schik AN, Carroll PR, Feng FY, Rowe SP, Lawhn-Heath C, Hope TA, Froelich JW. PMID: 34091713.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    72. Pitfalls on PET/MRI. Semin Nucl Med. 2021 09; 51(5):529-539. Afaq A, Faul D, Chebrolu VV, Wan S, Hope TA, Haibach PV, Bomanji J. PMID: 34020770.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    73. Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer. Eur Urol. 2021 06; 79(6):717-721. Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, Carroll PR, Schaeffer E, Feng FY. PMID: 33840559.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    74. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas. 2021 04 01; 50(4):469-493. Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, Dahia PLM, Fraker DL, Goodman KA, Hope TA, Kunz PL, Perez K, Perrier ND, Pryma DA, Ryder M, Sasson AR, Soulen MC, Jimenez C. PMID: 33939658.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    75. More Answers and More Questions About Radiotherapy for Metastatic Prostate Cancer. JAMA Oncol. 2021 04 01; 7(4):563-564. Koontz BF, Hope TA. PMID: 33599702.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Prostate-specific Membrane Antigen PET in Prostate Cancer. Radiology. 2021 05; 299(2):248-260. Lawhn-Heath C, Salavati A, Behr SC, Rowe SP, Calais J, Fendler WP, Eiber M, Emmett L, Hofman MS, Hope TA. PMID: 33787338.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    77. Reply: Disparities in PET Imaging of Prostate Cancer at a Tertiary Academic Medical Center. J Nucl Med. 2021 05 10; 62(5):748. Bucknor MD, Hope TA. PMID: 33741646.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    78. High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma. Clin Cancer Res. 2021 06 01; 27(11):2989-2995. Jha A, Taïeb D, Carrasquillo JA, Pryma DA, Patel M, Millo C, de Herder WW, Del Rivero J, Crona J, Shulkin BL, Virgolini I, Chen AP, Mittal BR, Basu S, Dillon JS, Hope TA, Mari Aparici C, Iagaru AH, Hicks RJ, Avram AM, Strosberg JR, Civelek AC, Lin FI, Pandit-Taskar N, Pacak K. PMID: 33685867; PMCID: PMC8172462.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    79. Accuracy of 18F-Fluorocholine PET for the Detection of Parathyroid Adenomas: Prospective Single-Center Study. J Nucl Med. 2021 11; 62(11):1511-1516. Hope TA, Graves CE, Calais J, Ehman EC, Johnson GB, Thompson D, Aslam M, Duh QY, Gosnell JE, Shen WT, Roman SA, Sosa JA, Kluijfhout WP, Seib CD, Villaneuva-Meyer JE, Pampaloni MH, Suh I. PMID: 33674400; PMCID: PMC8612343.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    80. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. Eur J Nucl Med Mol Imaging. 2021 05; 48(5):1626-1638. Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, Eiber M, Haberkorn U, Hofman MS, Hope TA, Kumar R, Rowe SP, Schwarzenboeck SM, Fanti S, Herrmann K. PMID: 33604691; PMCID: PMC8113168.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    81. PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer. Lancet. 2021 02 27; 397(10276):768-769. Hope TA, Calais J. PMID: 33581799.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    82. The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer. Eur Urol Focus. 2021 03; 7(2):258-266. Murthy V, Sonni I, Jariwala N, Juarez R, Reiter RE, Raman SS, Hope TA. PMID: 33541838.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    83. Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA. J Nucl Med. 2021 02; 62(2):146-148. Sartor O, Hope TA, Calais J, Fendler WP. PMID: 33468543.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrow. Phys Med Biol. 2021 01 29; 66(3):035016. Tranel J, Feng FY, James SS, Hope TA. PMID: 33321484; PMCID: PMC7880907.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    85. Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis. J Nucl Med. 2021 09 01; 62(9):1285-1291. Whitman J, Allen IE, Bergsland EK, Suh I, Hope TA. PMID: 33452040; PMCID: PMC8882892.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    86. Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome. Eur Urol Focus. 2021 03; 7(2):238-240. Calais J, Armstrong WR, Kishan AU, Booker KM, Hope TA, Fendler WP, Elashoff D, Nickols NG, Czernin J. PMID: 33386288; PMCID: PMC8057677.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    87. Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET. J Nucl Med. 2020 12; 61(12):1764. Hope TA. PMID: 33262268.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    88. From Compassionate Use to Phase 3 Trial: The Impact of Germany's PSMA-617 Literature. J Nucl Med. 2020 12; 61(Suppl 2):255S-256S. Hope TA. PMID: 33293446.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    89. Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer. Cancer Med. 2021 01; 10(1):62-69. Borno HT, Kuo Lin T, Odisho AY, Desai A, Koshkin V, Werner K, Legaspi N, Bucknor M, Bell A, Zhang S, Hope TA. PMID: 33247633; PMCID: PMC7826487.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    90. Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study. EJNMMI Res. 2020 Oct 22; 10(1):128. Lawhn-Heath C, Yom SS, Liu C, Villanueva-Meyer JE, Aslam M, Smith R, Narwal M, Juarez R, Behr SC, Pampaloni MH, Chan JW, Glastonbury CM, Hope TA, Flavell RR. PMID: 33090273; PMCID: PMC7581659.
      View in: PubMed   Mentions: 12  
    91. Introduction to the D-SPECT for Technologists: Workflow Using a Dedicated Digital Cardiac Camera. J Nucl Med Technol. 2020 Dec; 48(4):297-303. Johnson RD, Bath NK, Rinker J, Fong S, St James S, Pampaloni MH, Hope TA. PMID: 33020236.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    92. Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center. J Nucl Med. 2021 05 10; 62(5):695-699. Bucknor MD, Lichtensztajn DY, Lin TK, Borno HT, Gomez SL, Hope TA. PMID: 32978283.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    93. A Conversation Between Joseph Osborne and Thomas Hope. J Nucl Med. 2020 09; 61(9):1275-1277. Osborne JR, Hope TA. PMID: 32873736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    94. NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):174-185. Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF. PMID: 32861817; PMCID: PMC7736505.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    95. 68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality. EJNMMI Phys. 2020 Aug 26; 7(1):54. Murthy V, Smith RL, Tao DH, Lawhn-Heath CA, Korenchan DE, Larson PEZ, Flavell RR, Hope TA. PMID: 32844310; PMCID: PMC7447708.
      View in: PubMed   Mentions: 3  
    96. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Eur J Nucl Med Mol Imaging. 2021 02; 48(2):501-508. Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, PSMA PET Reader Group, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin J, Hope TA. PMID: 32808077; PMCID: PMC7835157.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    97. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors. Pancreas. 2020 08; 49(7):863-881. Halfdanarson TR, Strosberg JR, Tang L, Bellizzi AM, Bergsland EK, O'Dorisio TM, Halperin DM, Fishbein L, Eads J, Hope TA, Singh S, Salem R, Metz DC, Naraev BG, Reidy-Lagunes DL, Howe JR, Pommier RF, Menda Y, Chan JA. PMID: 32675783.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    98. PET/Magnetic Resonance Imaging Applications in Abdomen and Pelvis. Magn Reson Imaging Clin N Am. 2020 Aug; 28(3):369-380. Panda A, Goenka AH, Hope TA, Veit-Haibach P. PMID: 32624155.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    99. Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. J Thorac Oncol. 2020 10; 15(10):1577-1598. Singh S, Bergsland EK, Card CM, Hope TA, Kunz PL, Laidley DT, Lawrence B, Leyden S, Metz DC, Michael M, Modahl LE, Myrehaug S, Padda SK, Pommier RF, Ramirez RA, Soulen M, Strosberg J, Sung A, Thawer A, Wei B, Xu B, Segelov E. PMID: 32663527.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    100. MR-based Attenuation Correction for Brain PET Using 3D Cycle-Consistent Adversarial Network. IEEE Trans Radiat Plasma Med Sci. 2021 Mar; 5(2):185-192. Gong K, Yang J, Larson PEZ, Behr SC, Hope TA, Seo Y, Li Q. PMID: 33778235; PMCID: PMC7993643.
      View in: PubMed   Mentions: 14  
    101. North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19. Pancreas. 2020 07; 49(6):723-728. Bergsland EK, Halperin DM, Dillon JS, Dasari NA, Kunz PL, Soares HP, Pryma D, Bodei L, Hope T, Soulen MC, Mailman J, Howe JR. PMID: 32433264; PMCID: PMC7253037.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    102. Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? J Nucl Med. 2020 Aug; 61(8):1094-1095. Bodei L, Bergsland E, de Herder WW, Ferone D, Hicks RJ, Hope TA, Kunikowska J, Pavel M, Reidy-Lagunes D, Siveke J, Strosberg J, Dittmer U, Herrmann K. PMID: 32576637; PMCID: PMC7413236.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    103. Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors. J Nucl Med. 2021 02; 62(2):221-227. Lawhn-Heath C, Fidelman N, Chee B, Jivan S, Armstrong E, Zhang L, Lindsay S, Bergsland EK, Hope TA. PMID: 32513903.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    104. Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. J Nucl Med. 2020 12; 61(12):1793-1799. Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA. PMID: 32358094; PMCID: PMC9364898.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    105. Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer. J Nucl Med. 2020 12; 61(12):1779-1785. Chiu LW, Lawhn-Heath C, Behr SC, Juarez R, Perez PM, Lobach I, Bucknor MD, Hope TA, Flavell RR. PMID: 32303599.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    106. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors. J Surg Oncol. 2020 Aug; 122(2):204-211. Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. PMID: 32291778.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment. J Nucl Med. 2020 04; 61(4):552-562. Jadvar H, Ballas LK, Choyke PL, Fanti S, Gulley JL, Herrmann K, Hope TA, Klitzke AK, Oldan JD, Pomper MG, Rowe SP, Subramaniam RM, Taneja SS, Vargas HA, Ahuja S. PMID: 32238495.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    108. A Conversation with John Sunderland, Johannes Czernin, and Thomas Hope. J Nucl Med. 2020 04; 61(4):477-479. Sunderland JJ, Czernin J, Hope T. PMID: 32238494.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    109. Bone material analogues for PET/MRI phantoms. Med Phys. 2020 Jun; 47(5):2161-2170. Chandramohan D, Cao P, Han M, An H, Sunderland JJ, Kinahan PE, Laforest R, Hope TA, Larson PEZ. PMID: 32034945; PMCID: PMC7901472.
      View in: PubMed   Mentions: 5     Fields:    
    110. NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy. J Nucl Med. 2020 02; 61(2):222-227. Hope TA, Bodei L, Chan JA, El-Haddad G, Fidelman N, Kunz PL, Mailman J, Menda Y, Metz DC, Mittra ES, Pryma DA, Reidy-Lagunes DL, Singh S, Strosberg JR. PMID: 32015164; PMCID: PMC9364765.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    111. Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. J Clin Oncol. 2020 06 10; 38(17):1963-1996. Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA. PMID: 31940221.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    112. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors. Pancreas. 2020 01; 49(1):1-33. Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, Minter RM, Lairmore TC, Tseng JF, Zeh HJ, Libutti SK, Singh G, Lee JE, Hope TA, Kim MK, Menda Y, Halfdanarson TR, Chan JA, Pommier RF. PMID: 31856076; PMCID: PMC7029300.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    113. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2019 Dec 11. Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK. PMID: 31828813.
      View in: PubMed   Mentions: 3     Fields:    
    114. Complete Response and Immune-Mediated Adverse Effects With Checkpoint Blockade: Treatment of Mismatch Repair-Deficient Colorectal Neuroendocrine Carcinoma. JCO Precis Oncol. 2019 Dec; 3:1-7. Whitman J, Kardosh A, Diaz L, Fong L, Hope T, Onodera C, Joseph N, Le D, Fisher G, Bergsland E. PMID: 35100735.
      View in: PubMed   Mentions: 1     Fields:    
    115. What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply. Lancet Oncol. 2019 11; 20(11):e609-e610. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Fendler WP, Czernin J. PMID: 31674314.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    116. Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol (NY). 2019 11; 44(11):3569-3580. Horvat N, Hope TA, Pickhardt PJ, Petkovska I. PMID: 30993392; PMCID: PMC7357860.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    117. The use of PET/MRI for imaging rectal cancer. Abdom Radiol (NY). 2019 11; 44(11):3559-3568. Hope TA, Kassam Z, Loening A, McNamara MM, Paspulati R. PMID: 31201431; PMCID: PMC7001508.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    118. Rectal cancer lexicon: consensus statement from the society of abdominal radiology rectal & anal cancer disease-focused panel. Abdom Radiol (NY). 2019 11; 44(11):3508-3517. Hope TA, Gollub MJ, Arya S, Bates DDB, Ganeshan D, Harisinghani M, Jhaveri KS, Kassam Z, Kim DH, Korngold E, Lalwani N, Moreno CC, Nougaret S, Paroder V, Paspulati RM, Golia Pernicka JS, Petkovska I, Pickhardt PJ, Rauch GM, Rosenthal MH, Sheedy SP, Horvat N. PMID: 31388697; PMCID: PMC6824987.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    119. Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors. J Surg Oncol. 2019 Dec; 120(8):1311-1317. Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. PMID: 31613999.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    120. Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2019 12 15; 25(24):7448-7454. Fendler WP, Weber M, Iravani A, Hofman MS, Calais J, Czernin J, Ilhan H, Saad F, Small EJ, Smith MR, Perez PM, Hope TA, Rauscher I, Londhe A, Lopez-Gitlitz A, Cheng S, Maurer T, Herrmann K, Eiber M, Hadaschik B. PMID: 31511295.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    121. A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer. BMC Cancer. 2019 Sep 11; 19(1):906. Savoie MB, Laffan A, Brickman C, Daniels B, Levin A, Rowen T, Smith J, Van Blarigan EL, Hope TA, Berry-Lawhorn JM, Anwar M, Van Loon K. PMID: 31510960; PMCID: PMC6737598.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    122. EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019 Nov; 46(12):2536-2544. Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. PMID: 31440799.
      View in: PubMed   Mentions: 124     Fields:    Translation:Humans
    123. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy. Mol Pharm. 2019 09 03; 16(9):3831-3841. Wang S, Blaha C, Santos R, Huynh T, Hayes TR, Beckford-Vera DR, Blecha JE, Hong AS, Fogarty M, Hope TA, Raleigh DR, Wilson DM, Evans MJ, VanBrocklin HF, Ozawa T, Flavell RR. PMID: 31381351; PMCID: PMC6722010.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    124. Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period. Endocr Connect. 2019 Aug; 8(8):1149-1158. Silverstein J, Kidder W, Fisher S, Hope TA, Maisel S, Ng D, Van Ziffle J, Atreya CE, Van Loon K. PMID: 31370007; PMCID: PMC6686950.
      View in: PubMed   Mentions: 3  
    125. Correlation of DOTATOC Uptake and Pathologic Grade in Neuroendocrine Tumors. Pancreas. 2019 08; 48(7):948-952. Chan H, Moseley C, Zhang L, Bergsland EK, Pampaloni MH, Van Loon K, Hope TA. PMID: 31268975.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    126. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019 09; 20(9):1286-1294. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. PMID: 31375469; PMCID: PMC7469487.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCTClinical Trials
    127. Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection? J Nucl Med. 2020 02; 61(2):189-193. Rauscher I, Fendler WP, Hope TA, Quon A, Nekolla SG, Calais J, Richter A, Haller B, Herrmann K, Weber WA, Czernin J, Eiber M. PMID: 31324710; PMCID: PMC8801954.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    128. NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. J Nucl Med. 2019 07; 60(7):937-943. Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, Strosberg JR. PMID: 31263080.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    129. Author Reply. Urology. 2019 07; 129:163-164. Boreta L, Gadzinski AJ, Hope TA, Feng FY. PMID: 31234998.
      View in: PubMed   Mentions: 1     Fields:    
    130. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 01; 5(6):856-863. Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA. PMID: 30920593; PMCID: PMC6567829.
      View in: PubMed   Mentions: 231     Fields:    Translation:HumansCTClinical Trials
    131. Summary of the First ISMRM-SNMMI Workshop on PET/MRI: Applications and Limitations. J Nucl Med. 2019 10; 60(10):1340-1346. Hope TA, Fayad ZA, Fowler KJ, Holley D, Iagaru A, McMillan AB, Veit-Haiback P, Witte RJ, Zaharchuk G, Catana C. PMID: 31123099; PMCID: PMC6785790.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    132. Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer. AJR Am J Roentgenol. 2019 08; 213(2):266-274. Lawhn-Heath C, Flavell RR, Behr SC, Yohannan T, Greene KL, Feng F, Carroll PR, Hope TA. PMID: 31039025.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    133. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology. 2019 07; 129:165-171. Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. PMID: 30928607.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    134. Spatial gradients of healthy aging: a study of myelin-sensitive maps. Neurobiol Aging. 2019 07; 79:83-92. Karolis VR, Callaghan MF, Tseng CJ, Hope T, Weiskopf N, Rees G, Cappelletti M. PMID: 31029019.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    135. Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities-Phase III Studies. J Nucl Med. 2019 06; 60(6):736-744. Gambhir SS, Shankar LK, Rosenthal E, Warram JM, Ghesani M, Hope TA, Jacobs PM, Jacobson GB, Wilson T, Siegel BA. PMID: 30850482; PMCID: PMC6581222.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    136. 111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden. J Nucl Med. 2019 09; 60(9):1266-1269. Hope TA, Calais J, Zhang L, Dieckmann W, Millo C. PMID: 30850506; PMCID: PMC6735279.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    137. AUTHOR REPLY. Urology. 2019 03; 125:161-162. Wu SY, Feng FY, Hope TA. PMID: 30798967.
      View in: PubMed   Mentions:    Fields:    
    138. Ectopic Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma of the Nasopharynx Diagnosed by Gallium 68 DOTATATE Positron Emission Tomography/Computed Tomography. World Neurosurg. 2019 05; 125:400-404. Kim S, Dillon WP, Hope TA, El-Sayed IH, van Zante A, Wu K, Masharani U. PMID: 30797906.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    139. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. Eur Urol Oncol. 2019 11; 2(6):685-690. Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY. PMID: 31411984.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    140. Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases. Clin Nucl Med. 2019 Jan; 44(1):e28-e32. Perez PM, Hope TA, Behr SC, van Zante A, Small EJ, Flavell RR. PMID: 30394930.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    141. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    142. WITHDRAWN: PSMA-PET: a maturing tool. Urology. 2018 Dec 20. Wu SY, Feng FY, Hope TA. PMID: 30580008.
      View in: PubMed   Mentions:    Fields:    
    143. Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology. J Nucl Med. 2019 06; 60(6):786-793. Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR. PMID: 30530831; PMCID: PMC6581235.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    144. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. J Nucl Med. 2019 07; 60(7):910-916. Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. PMID: 30464040; PMCID: PMC6604687.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    145. Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting. Prostate. 2019 02; 79(3):244-258. Miyahira AK, Den RB, Carlo MI, de Leeuw R, Hope TA, Karzai F, McKay RR, Salami SS, Simons JW, Pienta KJ, Soule HR. PMID: 30381857.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    146. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018 12; 289(3):730-737. Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. PMID: 30226456; PMCID: PMC6283324.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    147. Developing an efficient phase-matched attenuation correction method for quiescent period PET in abdominal PET/MRI. Phys Med Biol. 2018 09 10; 63(18):185002. Yang J, Liu J, Wiesinger F, Menini A, Zhu X, Hope TA, Seo Y, Larson PEZ. PMID: 30106008; PMCID: PMC6175705.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    148. Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT. Clin Genitourin Cancer. 2019 02; 17(1):e53-e55. Polverari G, Ceci F, Allen-Auerbach M, Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM, Czernin J, Calais J. PMID: 30293922.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    149. Does Extended PET Acquisition in PET/MRI Rectal Cancer Staging Improve Results? AJR Am J Roentgenol. 2018 10; 211(4):896-900. Bailey JJ, Jordan EJ, Burke C, Ohliger MA, Wang ZJ, Van Loon K, Varma MG, Hope TA. PMID: 30106609; PMCID: PMC7000107.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    150. PET/MR Imaging of the Pancreas. Magn Reson Imaging Clin N Am. 2018 Aug; 26(3):345-362. Mallak N, Hope TA, Guimaraes AR. PMID: 30376974.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    151. Prostate cancer PET tracers: essentials for the urologist. Can J Urol. 2018 08; 25(4):9371-9383. Fraum TJ, Ludwig DR, Kim EH, Schroeder P, Hope TA, Ippolito JE. PMID: 30125515.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    152. PET/MRI for Gastrointestinal Imaging: Current Clinical Status and Future Prospects. Gastroenterol Clin North Am. 2018 09; 47(3):691-714. Fraum TJ, Ludwig DR, Hope TA, Fowler KJ. PMID: 30115444.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    153. Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer. Eur J Nucl Med Mol Imaging. 2018 11; 45(12):2045-2054. Afshar-Oromieh A, Debus N, Uhrig M, Hope TA, Evans MJ, Holland-Letz T, Giesel FL, Kopka K, Hadaschik B, Kratochwil C, Haberkorn U. PMID: 29980832; PMCID: PMC6182397.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    154. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma. Abdom Radiol (NY). 2018 07; 43(7):1627-1633. Lee JY, Huo EJ, Weinstein S, Santos C, Monto A, Corvera CU, Yee J, Hope TA. PMID: 29018942; PMCID: PMC7815454.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    155. Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications. AJR Am J Roentgenol. 2018 08; 211(2):286-294. Hope TA, Afshar-Oromieh A, Eiber M, Emmett L, Fendler WP, Lawhn-Heath C, Rowe SP. PMID: 29949419; PMCID: PMC7001912.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    156. Clinical Evaluation of 68Ga-PSMA-II and 68Ga-RM2 PET Images Reconstructed With an Improved Scatter Correction Algorithm. AJR Am J Roentgenol. 2018 09; 211(3):655-660. Wangerin KA, Baratto L, Khalighi MM, Hope TA, Gulaka PK, Deller TW, Iagaru AH. PMID: 29873506.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    157. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer. Eur Urol Oncol. 2018 05; 1(1):78-82. Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T. PMID: 31100231.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    158. Ferumoxytol-enhanced MRI in the peripheral vasculature. Clin Radiol. 2019 01; 74(1):37-50. Lehrman ED, Plotnik AN, Hope T, Saloner D. PMID: 29731126; PMCID: PMC7437525.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    159. Variable refocusing flip angle single-shot fast spin echo imaging of liver lesions: increased speed and lesion contrast. Abdom Radiol (NY). 2018 03; 43(3):593-599. Hicks RM, Loening AM, Ohliger MA, Vasanawala SS, Hope TA. PMID: 28689221.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    160. Zero TE-based pseudo-CT image conversion in the head and its application in PET/MR attenuation correction and MR-guided radiation therapy planning. Magn Reson Med. 2018 10; 80(4):1440-1451. Wiesinger F, Bylund M, Yang J, Kaushik S, Shanbhag D, Ahn S, Jonsson JH, Lundman JA, Hope T, Nyholm T, Larson P, Cozzini C. PMID: 29457287.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    161. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol (NY). 2018 01; 43(1):56-74. Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, Ganesan K, Yaghmai V, Guimaraes AR, Sahani DV, Miller FH. PMID: 28940042.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    162. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol (NY). 2018 01; 43(1):149-157. Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. PMID: 28580538.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    163. Correction to: LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol (NY). 2018 01; 43(1):240. Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, Ganesan K, Yaghmai V, Guimaraes AR, Sahani DV, Miller FH. PMID: 29098367.
      View in: PubMed   Mentions:    Fields:    
    164. Letter to the editor response. Abdom Radiol (NY). 2018 01; 43(1):239. Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR, Sirlin CB, Tang A, Kielar A. PMID: 29167945.
      View in: PubMed   Mentions:    Fields:    
    165. Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction. Mol Imaging. 2018 Jan-Dec; 17:1536012118811741. Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, Hope TA. PMID: 31749411; PMCID: PMC6287320.
      View in: PubMed   Mentions: 3     Fields:    
    166. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT. J Nucl Med. 2018 03; 59(3):469-478. Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, Hope T, Reiter R, Maurer T, Weber WA, Fendler WP. PMID: 29123012.
      View in: PubMed   Mentions: 188     Fields:    Translation:Humans
    167. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI. J Nucl Med. 2018 05; 59(5):852-858. Leynes AP, Yang J, Wiesinger F, Kaushik SS, Shanbhag DD, Seo Y, Hope TA, Larson PEZ. PMID: 29084824; PMCID: PMC5932530.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    168. Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors. J Nucl Med. 2018 01; 59(1):66-74. Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O'Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR. PMID: 29025982; PMCID: PMC6910630.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    169. Motion robust high resolution 3D free-breathing pulmonary MRI using dynamic 3D image self-navigator. Magn Reson Med. 2018 06; 79(6):2954-2967. Jiang W, Ong F, Johnson KM, Nagle SK, Hope TA, Lustig M, Larson PEZ. PMID: 29023975; PMCID: PMC6474413.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    170. Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer. EJNMMI Res. 2017 Sep 19; 7(1):77. Lake ST, Greene KL, Westphalen AC, Behr SC, Zagoria R, Small EJ, Carroll PR, Hope TA. PMID: 28929350; PMCID: PMC5605480.
      View in: PubMed   Mentions: 16  
    171. The Role of PET/MR Imaging in Precision Medicine. PET Clin. 2017 Oct; 12(4):489-501. Huo E, Wilson DM, Eisenmenger L, Hope TA. PMID: 28867118.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    172. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017 Jun; 44(6):1014-1024. Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, Giesel F, Haberkorn U, Hope TA, Kopka K, Krause BJ, Mottaghy FM, Schöder H, Sunderland J, Wan S, Wester HJ, Fanti S, Herrmann K. PMID: 28283702.
      View in: PubMed   Mentions: 289     Fields:    Translation:HumansPHPublic Health
    173. PET/MR Imaging in Gynecologic Oncology. Magn Reson Imaging Clin N Am. 2017 Aug; 25(3):667-684. Ohliger MA, Hope TA, Chapman JS, Chen LM, Behr SC, Poder L. PMID: 28668166.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    174. Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2017 12; 58(12):1956-1961. Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR. PMID: 28522741.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    175. Evaluation of Sinus/Edge-Corrected Zero-Echo-Time-Based Attenuation Correction in Brain PET/MRI. J Nucl Med. 2017 11; 58(11):1873-1879. Yang J, Wiesinger F, Kaushik S, Shanbhag D, Hope TA, Larson PEZ, Seo Y. PMID: 28473594; PMCID: PMC6944168.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    176. Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography. J Comput Assist Tomogr. 2017 May/Jun; 41(3):376-381. Hope TA, Aslam R, Weinstein S, Yeh BM, Corvera CU, Monto A, Yee J. PMID: 27801693; PMCID: PMC5411341.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    177. 68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study. J Nucl Med. 2017 10; 58(10):1617-1623. Fendler WP, Calais J, Allen-Auerbach M, Bluemel C, Eberhardt N, Emmett L, Gupta P, Hartenbach M, Hope TA, Okamoto S, Pfob CH, Pöppel TD, Rischpler C, Schwarzenböck S, Stebner V, Unterrainer M, Zacho HD, Maurer T, Gratzke C, Crispin A, Czernin J, Herrmann K, Eiber M. PMID: 28408531.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    178. Technical Note: Fast respiratory motion estimation using sorted singles without unlist processing: A feasibility study. Med Phys. 2017 May; 44(5):1632-1637. Yang J, Khalighi M, Hope TA, Ordovas K, Seo Y. PMID: 28099995.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    179. Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT. Clin Nucl Med. 2017 Apr; 42(4):e218-e220. Lawhn-Heath C, Flavell RR, Glastonbury C, Hope TA, Behr SC. PMID: 28166149.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    180. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017 11; 46(5):1247-1262. Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, Hope TA. PMID: 28370695; PMCID: PMC5623147.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    181. Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI. Med Phys. 2017 Mar; 44(3):902-913. Leynes AP, Yang J, Shanbhag DD, Kaushik SS, Seo Y, Hope TA, Wiesinger F, Larson PE. PMID: 28112410; PMCID: PMC5877454.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    182. Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement. Abdom Radiol (NY). 2017 03; 42(3):870-876. Ikram NS, Yee J, Weinstein S, Yeh BM, Corvera CU, Monto A, Hope TA. PMID: 27770162; PMCID: PMC5357156.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    183. Quantitative Evaluation of Atlas-based Attenuation Correction for Brain PET in an Integrated Time-of-Flight PET/MR Imaging System. Radiology. 2017 07; 284(1):169-179. Yang J, Jian Y, Jenkins N, Behr SC, Hope TA, Larson PEZ, Vigneron D, Seo Y. PMID: 28234560.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    184. 18F Fluorocholine PET/MR Imaging in Patients with Primary Hyperparathyroidism and Inconclusive Conventional Imaging: A Prospective Pilot Study. Radiology. 2017 08; 284(2):460-467. Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh QY, Vriens MR, de Keizer B, Hope TA, Glastonbury CM, Pampaloni MH, Suh I. PMID: 28121522.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    185. Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis. Eur J Radiol. 2017 Mar; 88:117-128. Kluijfhout WP, Pasternak JD, Beninato T, Drake FT, Gosnell JE, Shen WT, Duh QY, Allen IE, Vriens MR, de Keizer B, Hope TA, Suh I. PMID: 28189196.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    186. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016 11; 41(11):2161-2168. Ehman EC, Umetsu SE, Ohliger MA, Fidelman N, Ferrell LD, Yeh BM, Yee J, Hope TA. PMID: 27484789.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    187. SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer. J Nucl Med. 2017 01; 58(1):11-12. Zukotynski K, Jadvar H, Hope T, Subramaniam RM, Van Loon K, Varma M, Niederkohr RD, PET Center of Excellence. PMID: 27688471.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    188. 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience. J Nucl Med. 2017 Jan; 58(1):81-84. Hope TA, Truillet C, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, Carroll PR, Small EJ, Evans MJ. PMID: 27660139; PMCID: PMC5209643.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansAnimalsCells
    189. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent. Abdom Radiol (NY). 2016 08; 41(8):1522-31. Kim SY, Wu EH, Park SH, Wang ZJ, Hope TA, Yee J, Zhao LQ, Chang WC, Yeh BM. PMID: 26971341; PMCID: PMC5297255.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    190. Targeted PET imaging for prostate-specific membrane antigen in prostate cancer. Future Oncol. 2016 Nov; 12(21):2393-2396. Hope TA, Aggarwal RR, Westphalen AC, Cooperberg MR, Greene KL. PMID: 27453303.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    191. Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism. Surgery. 2016 09; 160(3):747-54. Kluijfhout WP, Venkatesh S, Beninato T, Vriens MR, Duh QY, Wilson DM, Hope TA, Suh I. PMID: 27318765.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    192. Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing. Eur J Nucl Med Mol Imaging. 2016 Aug; 43(9):1611-20. Afshar-Oromieh A, Hetzheim H, Kübler W, Kratochwil C, Giesel FL, Hope TA, Eder M, Eisenhut M, Kopka K, Haberkorn U. PMID: 27260521.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    193. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY). 2016 05; 41(5):963-9. Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, Hope TA. PMID: 27193793; PMCID: PMC5292939.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    194. Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma. Magn Reson Imaging. 2016 Sep; 34(7):915-21. Hicks RM, Yee J, Ohliger MA, Weinstein S, Kao J, Ikram NS, Hope TA. PMID: 27108359; PMCID: PMC5325126.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    195. Transient washout of hepatic hemangiomas: Potential pitfall mimicking malignancy. Radiol Case Rep. 2016 Jun; 11(2):62-6. Becker-Weidman DJ, Hope TA, Doshi PH, Patel A, Mitchell DG. PMID: 27257451; PMCID: PMC4878935.
      View in: PubMed   Mentions: 3  
    196. Safety and technique of ferumoxytol administration for MRI. Magn Reson Med. 2016 May; 75(5):2107-11. Vasanawala SS, Nguyen KL, Hope MD, Bridges MD, Hope TA, Reeder SB, Bashir MR. PMID: 26890830; PMCID: PMC4854636.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    197. Correcting for respiratory motion in liver PET/MRI: preliminary evaluation of the utility of bellows and navigated hepatobiliary phase imaging. EJNMMI Phys. 2015 Dec; 2(1):21. Hope TA, Verdin EF, Bergsland EK, Ohliger MA, Corvera CU, Nakakura EK. PMID: 26501822; PMCID: PMC4573645.
      View in: PubMed   Mentions: 8  
    198. Combined parenchymal and vascular imaging: High spatiotemporal resolution arterial evaluation of hepatocellular carcinoma. J Magn Reson Imaging. 2016 Apr; 43(4):859-65. Hope TA, Petkovska I, Saranathan M, Hargreaves BA, Vasanawala SS. PMID: 26340309.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    199. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor. Abdom Imaging. 2015 Aug; 40(6):1432-40. Hope TA, Pampaloni MH, Nakakura E, VanBrocklin H, Slater J, Jivan S, Aparici CM, Yee J, Bergsland E. PMID: 25820755.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    200. Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System. Radiology. 2016 Jan; 278(1):239-46. Burris NS, Johnson KM, Larson PE, Hope MD, Nagle SK, Behr SC, Hope TA. PMID: 26133050; PMCID: PMC4699498.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    201. Vascular Imaging With Ferumoxytol as a Contrast Agent. AJR Am J Roentgenol. 2015 Sep; 205(3):W366-73. Hope MD, Hope TA, Zhu C, Faraji F, Haraldsson H, Ordovas KG, Saloner D. PMID: 26102308; PMCID: PMC5130335.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    202. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses. AJR Am J Roentgenol. 2015 Jun; 204(6):1220-7. Kim SY, Park SH, Wu EH, Wang ZJ, Hope TA, Chang WC, Yeh BM. PMID: 26001231.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    203. Somatostatin imaging of neuroendocrine-differentiated prostate cancer. Clin Nucl Med. 2015 Jun; 40(6):540-1. Hope TA, Aggarwal R, Simko JP, VanBrocklin HF, Ryan CJ. PMID: 25783510.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    204. Greater asymmetric wall shear stress in Sievers' type 1/LR compared with 0/LAT bicuspid aortic valves after valve-sparing aortic root replacement. J Thorac Cardiovasc Surg. 2015 Jul; 150(1):59-68. Stephens EH, Hope TA, Kari FA, Kvitting JP, Liang DH, Herfkens RJ, Miller DC. PMID: 25956338.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    205. Hepatobiliary agents and their role in LI-RADS. Abdom Imaging. 2015 Mar; 40(3):613-25. Hope TA, Fowler KJ, Sirlin CB, Costa EA, Yee J, Yeh BM, Heiken JP. PMID: 25287679.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    206. Neuroendocrine tumors: beyond the abdomen. J Comput Assist Tomogr. 2014 Nov-Dec; 38(6):898-914. Jacobs MA, Weinstein S, Hope TA, Aslam R, Yee J, Coakley F. PMID: 25162290.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    207. MR imaging of diffuse liver disease: from technique to diagnosis. Radiol Clin North Am. 2014 Jul; 52(4):709-24. Hope TA, Ohliger MA, Qayyum A. PMID: 24889168.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    208. Functional and molecular imaging techniques in aortic aneurysm disease. Curr Opin Cardiol. 2013 Nov; 28(6):609-18. Hope MD, Hope TA. PMID: 24030165.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    209. Evaluation of Marfan patients status post valve-sparing aortic root replacement with 4D flow. Magn Reson Imaging. 2013 Nov; 31(9):1479-84. Hope TA, Kvitting JP, Hope MD, Miller DC, Markl M, Herfkens RJ. PMID: 23706513.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    210. Improvement of gadoxetate arterial phase capture with a high spatio-temporal resolution multiphase three-dimensional SPGR-Dixon sequence. J Magn Reson Imaging. 2013 Oct; 38(4):938-45. Hope TA, Saranathan M, Petkovska I, Hargreaves BA, Herfkens RJ, Vasanawala SS. PMID: 23371926.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    211. Intravenous vasopressin for the prevention of nontarget gastrointestinal embolization during liver-directed cancer treatment: experimental study in a porcine model. J Vasc Interv Radiol. 2012 Nov; 23(11):1505-12. Durack JC, Hope TA, Seo Y, Saeed M, He J, Wilson MW, Kerlan RK, Ring EJ. PMID: 22974656.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    212. Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model. Magn Reson Imaging. 2013 Jan; 31(1):139-44. Hope TA, Leboit PE, High WA, Fu Y, Brasch RC. PMID: 22898683.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    213. Gadolinium accumulation and fibrosis in the liver after administration of gadoxetate disodium in a rat model of active hepatic fibrosis. Radiology. 2012 Aug; 264(2):423-7. Hope TA, Doherty A, Fu Y, Aslam R, Qayyum A, Brasch RC. PMID: 22570507.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    214. Improved risk assessment for abdominal aortic aneurysm rupture: off-the-wall imaging. J Am Coll Cardiol. 2011 Dec 06; 58(24):2531-2. Hope TA, Hope MD. PMID: 22133854.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    215. 4D flow CMR in assessment of valve-related ascending aortic disease. JACC Cardiovasc Imaging. 2011 Jul; 4(7):781-7. Hope MD, Hope TA, Crook SE, Ordovas KG, Urbania TH, Alley MT, Higgins CB. PMID: 21757170.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    216. Impaired social recognition memory in recombination activating gene 1-deficient mice. Brain Res. 2011 Apr 06; 1383:187-95. McGowan PO, Hope TA, Meck WH, Kelsoe G, Williams CL. PMID: 21354115; PMCID: PMC3436067.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    217. Four-dimensional flow magnetic resonance imaging with wall shear stress analysis before and after repair of aortopulmonary fistula. Circ Cardiovasc Imaging. 2010 Nov; 3(6):766-8. Hope MD, Hope TA, Urbania TH, Higgins CB. PMID: 21081744.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    218. Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic flow patterns. Radiology. 2010 Apr; 255(1):53-61. Hope MD, Hope TA, Meadows AK, Ordovas KG, Urbania TH, Alley MT, Higgins CB. PMID: 20308444.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    219. Clinical evaluation of aortic coarctation with 4D flow MR imaging. J Magn Reson Imaging. 2010 Mar; 31(3):711-8. Hope MD, Meadows AK, Hope TA, Ordovas KG, Saloner D, Reddy GP, Alley MT, Higgins CB. PMID: 20187217.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    220. Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron. Radiology. 2009 Nov; 253(2):390-8. Hope TA, High WA, Leboit PE, Chaopathomkul B, Rogut VS, Herfkens RJ, Brasch RC. PMID: 19789237.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    221. Hemodynamics in Normal Cerebral Arteries: Qualitative Comparison of 4D Phase-Contrast Magnetic Resonance and Image-Based Computational Fluid Dynamics. J Eng Math. 2009 Aug 01; 64(4):367-378. Cebral JR, Putman CM, Alley MT, Hope T, Bammer R, Calamante F. PMID: 19684874; PMCID: PMC2726749.
      View in: PubMed   Mentions: 29  
    222. Evaluation of intracranial stenoses and aneurysms with accelerated 4D flow. Magn Reson Imaging. 2010 Jan; 28(1):41-6. Hope TA, Hope MD, Purcell DD, von Morze C, Vigneron DB, Alley MT, Dillon WP. PMID: 19577400.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    223. Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine. Invest Radiol. 2009 Mar; 44(3):135-9. Hope TA, Herfkens RJ, Denianke KS, LeBoit PE, Hung YY, Weil E. PMID: 19151610.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    224. Initial experience characterizing a type I endoleak from velocity profiles using time-resolved three-dimensional phase-contrast MRI. J Vasc Surg. 2009 Jun; 49(6):1580-4. Hope TA, Zarins CK, Herfkens RJ. PMID: 19223146.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    225. Complete intracranial arterial and venous blood flow evaluation with 4D flow MR imaging. AJNR Am J Neuroradiol. 2009 Feb; 30(2):362-6. Hope MD, Purcell DD, Hope TA, von Morze C, Vigneron DB, Alley MT, Dillon WP. PMID: 18653687; PMCID: PMC7051404.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    226. Images in cardiovascular medicine. Evaluation of bicuspid aortic valve and aortic coarctation with 4D flow magnetic resonance imaging. Circulation. 2008 May 27; 117(21):2818-9. Hope MD, Meadows AK, Hope TA, Ordovas KG, Reddy GP, Alley MT, Higgins CB. PMID: 18506021.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    227. Imaging of the thoracic aorta with time-resolved three-dimensional phase-contrast MRI: a review. Semin Thorac Cardiovasc Surg. 2008; 20(4):358-64. Hope TA, Herfkens RJ. PMID: 19251177.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    228. Comparison of flow patterns in ascending aortic aneurysms and volunteers using four-dimensional magnetic resonance velocity mapping. J Magn Reson Imaging. 2007 Dec; 26(6):1471-9. Hope TA, Markl M, Wigström L, Alley MT, Miller DC, Herfkens RJ. PMID: 17968892.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    229. Time-resolved 3D quantitative flow MRI of the major intracranial vessels: initial experience and comparative evaluation at 1.5T and 3.0T in combination with parallel imaging. Magn Reson Med. 2007 Jan; 57(1):127-40. Bammer R, Hope TA, Aksoy M, Alley MT. PMID: 17195166; PMCID: PMC3985842.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Thomas's Networks
    Concepts (457)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (166)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.